Little T agree, T/0 price is hard to predict,
I like to think of Neuren's valuation as pre FDA approval and post FDA approval.
A T/O valuation pre FDA approval will be vastly different to one after. I'm hoping we are still around to see the full potential of this company with milestone payments and double digit royalties. Valuation $15 to $20 after Trofs approval.
Share Price, page-586
-
- There are more pages in this discussion • 11,578 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |